Cefotetan-induced hemolytic anemia after perioperative prophylaxis

American Journal of Hematology

Volumn 81, Issue 3, 2006, Pages 186-188

  Martin, Monte E ^a,b   Laber, Damian A ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTETAN; CEPHALOSPORIN;

ACQUIRED HEMOLYTIC ANEMIA; ADULT; ANEMIA; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; BLOOD TRANSFUSION; CASE REPORT; COOMBS TEST; DRUG ABSORPTION; EARLY DIAGNOSIS; ERYTHROCYTE CONCENTRATE; FATIGUE; FEMALE; FEVER; HOSPITALIZATION; HUMAN; HYPOXIA; IMMUNE COMPLEX DISEASE; INFECTION PREVENTION; JAUNDICE; LETHARGY; NAUSEA; PATIENT COUNSELING; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SIDE EFFECT; URINE COLOR; WEAKNESS; WEIGHT REDUCTION;

ADULT; ANEMIA, HEMOLYTIC; ANTI-BACTERIAL AGENTS; ANTIGEN-ANTIBODY COMPLEX; BLOOD TRANSFUSION; CEFOTETAN; ERYTHROCYTE MEMBRANE; FEMALE; HEMOLYSIS; HUMANS; INTRAOPERATIVE COMPLICATIONS; MIDDLE AGED;

EID: 33644499795     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20459     Document Type: Article

References (7)

1. th edition. Philadelphia: Lippincott Williams & Wilkins; 2004. p 1157-1182.
2. Cefotetan disodium for injection. Prescribing information. Revised 10/02. Accessed at: http://www.FDA.org/medwatch/ safety/2003.
3. Sganga G. New perspectives in antibiotic prophylaxis for intra-abdominal surgery. J Hosp Infect 2002;50(Suppl A):S17-21.
4. Garratty G. Review: drug-induced immune hemolytic anemia-the last decade. Immunohematology 2004;20:3:137-143.
5. Davenport RD, Judd WJ, Dake LR. Persistence of cefotetan on red blood cells. Transfusion 2004;44:849-852.
6. Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse Drug React Tox Rev 2002;21:101-107.
7. Faich GA. Adverse-drug-reaction monitoring. N Engl J Med 1986; 314:1589-1592.